日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy

多发性骨髓瘤长期生存者在接受一线治疗数十年后仍表现出持续的免疫改变。

Raphael Lutz #,Florian Grünschläger #,Malte Simon #,Mohamed H S Awwad,Marcus Bauer,Schayan Yousefian,Niklas Beumer,Lea Jopp-Saile,Anastasia Sedlmeier,Llorenç Solé-Boldo,Bogdan Avanesyan,Dominik Vonficht,Patrick Stelmach,Georg Steinbuss,Tobias Boch,Simon Steiger,Marc-Andrea Baertsch,Nina Prokoph,Karsten Rippe,Brian G M Durie,Claudia Wickenhauser,Andreas Trumpp,Carsten Müller-Tidow,Daniel Hübschmann,Niels Weinhold,Marc S Raab,Benedikt Brors,Hartmut Goldschmidt,Charles D Imbusch,Michael Hundemer,Simon Haas

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients

预先存在的 T 细胞状况决定了多发性骨髓瘤患者对双特异性 T 细胞接合剂的反应

Mirco J Friedrich, Paola Neri, Niklas Kehl, Julius Michel, Simon Steiger, Michael Kilian, Noémie Leblay, Ranjan Maity, Roman Sankowski, Holly Lee, Elie Barakat, Sungwoo Ahn, Niels Weinhold, Karsten Rippe, Lukas Bunse, Michael Platten, Hartmut Goldschmidt, Carsten Müller-Tidow, Marc-Steffen Raab, Niz

High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders

高通量电子断层扫描显示中心粒过度伸长是浆细胞疾病的早期事件

Sebastian Köhrer #, Tobias Dittrich #, Martin Schorb, Niels Weinhold, Isabella Haberbosch, Mandy Börmel, Gabor Pajor, Hartmut Goldschmidt, Carsten Müller-Tidow, Marc S Raab, Lukas John, Anja Seckinger, Alexander Brobeil, Peter Dreger, Tamás Tornóczky, László Pajor, Ute Hegenbart, Stefan O Schönland,

A high-throughput electron tomography workflow reveals over-elongated centrioles in relapsed/refractory multiple myeloma

高通量电子断层扫描工作流程揭示了复发/难治性多发性骨髓瘤中过度延长的中心粒

Tobias Dittrich, Sebastian Köhrer, Martin Schorb, Isabella Haberbosch, Mandy Börmel, Hartmut Goldschmidt, Gabor Pajor, Carsten Müller-Tidow, Marc S Raab, Ute Hegenbart, Stefan O Schönland, Yannick Schwab, Alwin Krämer

COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view

多发性骨髓瘤患者中的 COVID-19:短期和长期对 SARS-CoV-2 的细胞和体液免疫

Ivana von Metzler, Julia Campe, Sabine Huenecke, Marc S Raab, Hartmut Goldschmidt, Ralf Schubert, Holger F Rabenau, Sandra Ciesek, Hubert Serve, Evelyn Ullrich

Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics

单细胞转录组学揭示难治性多发性骨髓瘤中亚克隆特异性微环境影响和药物反应

Stephan M Tirier, Jan-Philipp Mallm, Simon Steiger, Alexandra M Poos, Mohamed H S Awwad, Nicola Giesen, Nicola Casiraghi, Hana Susak, Katharina Bauer, Anja Baumann, Lukas John, Anja Seckinger, Dirk Hose, Carsten Müller-Tidow, Hartmut Goldschmidt, Oliver Stegle, Michael Hundemer, Niels Weinhold, Marc

JunB is a key regulator of multiple myeloma bone marrow angiogenesis

JunB 是多发性骨髓瘤骨髓血管生成的关键调节剂

Fengjuan Fan, Stefano Malvestiti, Sonia Vallet, Judith Lind, Jose Manuel Garcia-Manteiga, Eugenio Morelli, Qinyue Jiang, Anja Seckinger, Dirk Hose, Hartmut Goldschmidt, Andreas Stadlbauer, Chunyan Sun, Heng Mei, Martin Pecherstorfer, Latifa Bakiri, Erwin F Wagner, Giovanni Tonon, Martin Sattler, Yu

CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment

CAMK1D 引发对抗 PD-L1 治疗有抵抗力的人类肿瘤细胞的免疫耐药性

Valentina Volpin, Tillmann Michels, Antonio Sorrentino, Ayse N Menevse, Gertrud Knoll, Madlen Ditz, Vladimir M Milenkovic, Chih-Yeh Chen, Anchana Rathinasamy, Klaus Griewank, Michael Boutros, Sebastian Haferkamp, Mark Berneburg, Christian H Wetzel, Anja Seckinger, Dirk Hose, Hartmut Goldschmidt, Mar

The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression

5q15 上的多发性骨髓瘤风险等位基因会降低 ELL2 表达并增加核糖体基因表达

Mina Ali, Ram Ajore, Anna-Karin Wihlborg, Abhishek Niroula, Bhairavi Swaminathan, Ellinor Johnsson, Owen W Stephens, Gareth Morgan, Tobias Meissner, Ingemar Turesson, Hartmut Goldschmidt, Ulf-Henrik Mellqvist, Urban Gullberg, Markus Hansson, Kari Hemminki, Hareth Nahi, Anders Waage, Niels Weinhold, 

Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome

复发性骨髓瘤亚组中 FOXM1 上调导致预后不良

Chunyan Gu, Carol Holman, Ramakrishna Sompallae, Xuefang Jing, Michael Tomasson, Dirk Hose, Anja Seckinger, Fenghuang Zhan, Guido Tricot, Hartmut Goldschmidt, Ye Yang, Siegfried Janz